Valuing health to impact health policy and practice globally
At the forefront of an evolving healthcare system, health economists, health services researchers, implementation scientists and biostatisticians at the Centre for Applied Health Economics (CAHE) are conducting multidisciplinary research to deliver leading advice, with significant impact on policy.
World-class multidisciplinary research from the Centre delivers economic and health benefits through applying innovative methods and analysis, providing the catalyst for solutions to complex problems. The evidence we produce for health policy and practice impact enables translation to address real world problems in health and quality of life globally.
We are excited to influence the direction of health system development in our region and contribute knowledge and skill transfer to those countries who are embedding health technology assessment into their health systems.
Explore the Centre for Applied Health Economics
From the director
For over 18 years we have established a leading Centre in the field of applied health economics, driving safe, effective and efficient healthcare solutions that are responsive to consumer needs. We are situated within the School of Medicine and Dentistry .
Together with industry partners our economic evaluation, health technology assessment work and research translation efforts have continued to significantly influence high level policy decisions and practice in health services.
Professor Josh Byrnes
Director - Centre for Applied Health Economics
Griffith news
Funding gift for spinal injury clinical trial
18 Nov 2024
A clinical trial to test the efficacy and safety of the transplantation of nasal cells to treat chronic spinal cord…
First-ever biomechanics study of Indigenous weapons shows what made them so deadly
29 Oct 2024
World-first study determines the deadliest weapons made by Indigenous Australians.
Immune exhaustion at the core of new ME/CFS and Long COVID research
24 Oct 2024
Unlocking the secrets behind immune exhaustion in ME/CFS and Long COVID patients.
World-first clinical trial for treating spinal cord injury
21 Oct 2024
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat...
Get in touch
Contact the Centre for Applied Health Economics on (07) 3735 - 9117